US Patent Issued to OSE IMMUNOTHERAPEUTICS on Jan. 27 for "Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications" (French Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,533, issued on Jan. 27, was assigned to OSE IMMUNOTHERAPEUTICS (Nantes, France).

"Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications" was invented by Vanessa Gauttier (Reze, France), Nicolas Poirier (Grandchamps des Fontaines, France), Caroline Mary (Sainte-Pazanne, France) and Charlene Trilleaud (Reze, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides humanized anti-CMKLR1 compounds having an agonist capability on the interaction between Resolvin E1 and CMKLR1, and their uses for treating or preventing a disease, in particular wherein the resolution of inflammation is delayed or...